186 related articles for article (PubMed ID: 12678223)
1. Development of an in vitro potency test for tetanus vaccines: an immunoassay based on Hc fragment determination.
Prieur S; Broc S; Gal M; Poirier B; Fuchs F
Dev Biol (Basel); 2002; 111():37-46. PubMed ID: 12678223
[TBL] [Abstract][Full Text] [Related]
2. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
3. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
[TBL] [Abstract][Full Text] [Related]
4. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
van der Gun J; Akkermans A; Hendriksen C; van de Donk H
Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
[TBL] [Abstract][Full Text] [Related]
5. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975
[No Abstract] [Full Text] [Related]
6. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
Burkin MA; Sviridov VV; Perelygina OV
Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
[TBL] [Abstract][Full Text] [Related]
7. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.
Coombes L; Stickings P; Tierney R; Rigsby P; Sesardic D
J Immunol Methods; 2009 Oct; 350(1-2):142-9. PubMed ID: 19761770
[TBL] [Abstract][Full Text] [Related]
8. Passive haemagglutination tests using purified antigens covalently coupled to turkey erythrocytes.
Relyveld EH; Huet M; Lery L
Dev Biol Stand; 1996; 86():225-41. PubMed ID: 8785953
[TBL] [Abstract][Full Text] [Related]
9. Serological methods for potency testing of tetanus toxoid vaccines for human use.
Hendriksen C; Winsnes R
Dev Biol (Basel); 2002; 111():131-40. PubMed ID: 12678232
[TBL] [Abstract][Full Text] [Related]
10. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
Aggerbeck H; Heron I
Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
[TBL] [Abstract][Full Text] [Related]
11. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
Rosskopf U; Noeske K; Werner E
ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
[TBL] [Abstract][Full Text] [Related]
12. Detection of anti-tetanus toxoid antibody on modified polyacrylonitrile fibers.
Jain S; Chattopadhyay S; Jackeray R; Zainul Abid CK; Kumar M; Singh H
Talanta; 2010 Oct; 82(5):1876-83. PubMed ID: 20875591
[TBL] [Abstract][Full Text] [Related]
13. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
Hendriksen CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460
[TBL] [Abstract][Full Text] [Related]
14. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
Xing DK; McLellan K; Corbel MJ; Sesardic D
Biologicals; 1996 Mar; 24(1):57-65. PubMed ID: 8733602
[TBL] [Abstract][Full Text] [Related]
15. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
[No Abstract] [Full Text] [Related]
16. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development].
Kiessig ST; Jahn S; Porstmann T; von Baehr R
Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129
[TBL] [Abstract][Full Text] [Related]
17. The use of alternatives to animal tests in developing countries.
Hong HA; Hendriks J
Dev Biol Stand; 1999; 101():209-14. PubMed ID: 10566795
[TBL] [Abstract][Full Text] [Related]
18. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
Piersma SJ; Leenaars MP; Guzylack-Piriou L; Summerfield A; Hendriksen CF; McCullough KC
Vaccine; 2006 Apr; 24(16):3076-83. PubMed ID: 16504349
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin g antibodies to tetanus toxoid with reference standards and the impact on clinical practice.
van Hoeven KH; Dale C; Foster P; Body B
Clin Vaccine Immunol; 2008 Dec; 15(12):1751-4. PubMed ID: 18845832
[TBL] [Abstract][Full Text] [Related]
20. Screening of tetanus antibodies with the aid of dot-enzyme-linked immunosorbent assay (Dot-ELISA). Validation of the results using standard ELISA and passive hemagglutination test.
Bizzini B; Leonardi MS; Zummo S; Mastroeni P
Boll Ist Sieroter Milan; 1990 Jun; 69(2):391-3. PubMed ID: 2152298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
